3rd Quarter - Termination — CORNERSTONE GOVERNMENT AFFAIRS, INC. for VYRIPHARM ENTERPRISES, INC. (2022)

Firm

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Client

VYRIPHARM ENTERPRISES, INC.

Income

—

Expenses

—

Terminated

Aug 31, 2022

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

Lobbyist	Covered position, as disclosed
JOSEPH BISCHOFF	—
TONY ESSALIH	COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS	—

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Food Industry (safety, labeling, etc.) FOO

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

Lobbyist	Covered position, as disclosed
JOSEPH BISCHOFF	—
TONY ESSALIH	COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP)

Health Issues HCR

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

Lobbyist	Covered position, as disclosed
JOSEPH BISCHOFF	—
TONY ESSALIH	COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS	—

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.